ORMP
Price
$2.33
Change
-$0.04 (-1.69%)
Updated
Mar 21 closing price
Capitalization
93.93M
66 days until earnings call
VERV
Price
$5.55
Change
+$0.01 (+0.18%)
Updated
Mar 21 closing price
Capitalization
492.82M
46 days until earnings call
Ad is loading...

ORMP vs VERV

Header iconORMP vs VERV Comparison
Open Charts ORMP vs VERVBanner chart's image
Oramed Pharmaceuticals
Price$2.33
Change-$0.04 (-1.69%)
Volume$16.87K
Capitalization93.93M
Verve Therapeutics
Price$5.55
Change+$0.01 (+0.18%)
Volume$1.16M
Capitalization492.82M
ORMP vs VERV Comparison Chart
Loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ORMP vs. VERV commentary
Mar 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ORMP is a Hold and VERV is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 23, 2025
Stock price -- (ORMP: $2.33 vs. VERV: $5.55)
Brand notoriety: ORMP and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ORMP: 6% vs. VERV: 77%
Market capitalization -- ORMP: $93.93M vs. VERV: $492.82M
ORMP [@Biotechnology] is valued at $93.93M. VERV’s [@Biotechnology] market capitalization is $492.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $341.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ORMP’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 0 green FA rating(s).

  • ORMP’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 0 green, 5 red.
According to our system of comparison, both ORMP and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ORMP’s TA Score shows that 4 TA indicator(s) are bullish while VERV’s TA Score has 3 bullish TA indicator(s).

  • ORMP’s TA Score: 4 bullish, 6 bearish.
  • VERV’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ORMP is a better buy in the short-term than VERV.

Price Growth

ORMP (@Biotechnology) experienced а -2.51% price change this week, while VERV (@Biotechnology) price change was -7.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.39%. For the same industry, the average monthly price growth was -7.55%, and the average quarterly price growth was -5.60%.

Reported Earning Dates

ORMP is expected to report earnings on May 28, 2025.

VERV is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (+1.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($493M) has a higher market cap than ORMP($93.9M). VERV YTD gains are higher at: -1.862 vs. ORMP (-3.719). ORMP has higher annual earnings (EBITDA): 9.44M vs. VERV (-221.91M). VERV has more cash in the bank: 524M vs. ORMP (142M). ORMP has less debt than VERV: ORMP (429K) vs VERV (70M). VERV has higher revenues than ORMP: VERV (32.3M) vs ORMP (0).
ORMPVERVORMP / VERV
Capitalization93.9M493M19%
EBITDA9.44M-221.91M-4%
Gain YTD-3.719-1.862200%
P/E Ratio21.18N/A-
Revenue032.3M-
Total Cash142M524M27%
Total Debt429K70M1%
FUNDAMENTALS RATINGS
ORMP: Fundamental Ratings
ORMP
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
85
PRICE GROWTH RATING
1..100
57
P/E GROWTH RATING
1..100
39
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ORMPVERV
RSI
ODDS (%)
Bearish Trend 2 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
78%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
69%
Bearish Trend 6 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 16 days ago
82%
Bullish Trend 11 days ago
87%
Declines
ODDS (%)
Bearish Trend 10 days ago
82%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
89%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
ORMP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AZMCF1.200.13
+12.15%
Arizona Metals Corp.
NABZY10.34-0.06
-0.58%
National Australia Bank Ltd. (Victoria, Australia)
MTUAY184.55-2.63
-1.41%
MTU Aero Engines AG
AMIGY37.91-0.67
-1.75%
Admiral Group Plc.
APAAF0.07N/A
-5.97%
APPIA RARE EARTHS & URANIUM CORP.